WO2007138193A8 - Traitement d'une infection par un virus a arn a une arn polymerase arn dependante - Google Patents
Traitement d'une infection par un virus a arn a une arn polymerase arn dependante Download PDFInfo
- Publication number
- WO2007138193A8 WO2007138193A8 PCT/FR2007/000899 FR2007000899W WO2007138193A8 WO 2007138193 A8 WO2007138193 A8 WO 2007138193A8 FR 2007000899 W FR2007000899 W FR 2007000899W WO 2007138193 A8 WO2007138193 A8 WO 2007138193A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- rna
- nucleic acid
- virus
- acid sequence
- replication
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24241—Use of virus, viral particle or viral elements as a vector
- C12N2770/24243—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009512639A JP5301433B2 (ja) | 2006-05-30 | 2007-05-30 | Rnaウイルス及びrna−依存型rnaポリメラーゼによる感染治療 |
CA002653910A CA2653910A1 (fr) | 2006-05-30 | 2007-05-30 | Traitement d'une infection par un virus a arn a une arn polymerase arn dependante |
US12/302,678 US20110015255A1 (en) | 2006-05-30 | 2007-05-30 | Treatment of an infection by an rna virus due to an rna dependent rna polymerase |
EP07765973A EP2021482A1 (fr) | 2006-05-30 | 2007-05-30 | Traitement d'une infection par un virus à arn à une arn polymérase arn dépendante |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0604806A FR2901807B1 (fr) | 2006-05-30 | 2006-05-30 | Nouveau traitement d'une infection par le vhc |
FR06/04806 | 2006-05-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007138193A1 WO2007138193A1 (fr) | 2007-12-06 |
WO2007138193A8 true WO2007138193A8 (fr) | 2009-07-16 |
Family
ID=37726550
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2007/000899 WO2007138193A1 (fr) | 2006-05-30 | 2007-05-30 | Traitement d'une infection par un virus a arn a une arn polymerase arn dependante |
Country Status (6)
Country | Link |
---|---|
US (1) | US20110015255A1 (fr) |
EP (1) | EP2021482A1 (fr) |
JP (1) | JP5301433B2 (fr) |
CA (1) | CA2653910A1 (fr) |
FR (1) | FR2901807B1 (fr) |
WO (1) | WO2007138193A1 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9775894B2 (en) * | 2013-07-09 | 2017-10-03 | University Of Washington Through Its Center For Commercialization | Methods and compositions for activation of innate immune responses through RIG-I like receptor signaling |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19915178A1 (de) * | 1999-04-03 | 2000-10-05 | Univ Mainz Johannes Gutenberg | Hepatitis C Virus Zellkultursystem |
EP1278837A2 (fr) * | 2000-04-21 | 2003-01-29 | Boehringer Ingelheim (Canada) Ltd. | Sites d'initiation de novo interne de la polymerase hcv ns5b et leurs applications |
WO2002008447A2 (fr) * | 2000-07-24 | 2002-01-31 | Institute Of Molecular & Cell Biology | Acides nucleiques et procedes pour detecter une infection virale, decouvrir des medicaments candidats anti-viraux et determiner la resistance aux medicaments d'isolats viraux |
EP1360276A4 (fr) * | 2001-01-31 | 2004-12-15 | Bristol Myers Squibb Pharma Co | Systeme in vitro pour la replication de virus a arn polymerase arn dependante |
DE602005020761D1 (de) * | 2004-03-24 | 2010-06-02 | Achillion Pharmaceuticals Inc | R rna in einem zellfreien system sowie identifizierung von inhibitoren der rna-synthese |
-
2006
- 2006-05-30 FR FR0604806A patent/FR2901807B1/fr not_active Expired - Fee Related
-
2007
- 2007-05-30 WO PCT/FR2007/000899 patent/WO2007138193A1/fr active Application Filing
- 2007-05-30 JP JP2009512639A patent/JP5301433B2/ja not_active Expired - Fee Related
- 2007-05-30 EP EP07765973A patent/EP2021482A1/fr not_active Withdrawn
- 2007-05-30 US US12/302,678 patent/US20110015255A1/en not_active Abandoned
- 2007-05-30 CA CA002653910A patent/CA2653910A1/fr not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2021482A1 (fr) | 2009-02-11 |
JP2009538610A (ja) | 2009-11-12 |
FR2901807A1 (fr) | 2007-12-07 |
JP5301433B2 (ja) | 2013-09-25 |
WO2007138193A1 (fr) | 2007-12-06 |
FR2901807B1 (fr) | 2013-08-23 |
CA2653910A1 (fr) | 2007-12-06 |
US20110015255A1 (en) | 2011-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008116860A3 (fr) | Compositions d'arn double brin et procédés de traitement d'infections par le virus du papillome humain (hpv) | |
WO2006026388A3 (fr) | Techniques d'amplification d'acide nucleique avec une seule amorce | |
WO2006083800A3 (fr) | Silençage nucleique de gene de maladie d'huntington | |
WO2010090857A3 (fr) | Procédés d'amplification d'acides nucléiques du virus de l'hépatite c | |
WO2010141511A3 (fr) | Polynucléotides pour interférence arn multivalente, compositions et procédés pour les utiliser | |
WO2006041290A3 (fr) | Moyens et procedes permettant de contrer un organisme | |
WO2007146511A3 (fr) | Composés et procédés de modulation de l'expression génique | |
WO2007051045A3 (fr) | Compositions et methodes destinees a inhiber l'expression du gene huntingtine | |
WO2007017229A3 (fr) | Procede pour l'evolution ciblee continue de proteines in vitro | |
WO2007014275A3 (fr) | Integration et expression ciblees de sequences d'acides nucleiques exogenes | |
WO2008036933A3 (fr) | Compositions et procédés servant à inhiber l'expression du gène hamp | |
WO2008063203A3 (fr) | Compositions et méthodes de silençage efficace de gènes dans des végétaux | |
WO2012092569A3 (fr) | Compositions contenant des acides nucléiques immunostimulants et méthodes associées | |
WO2007134161A3 (fr) | Compositions et procédés d'inhibition de l'expression du gène pcsk9 | |
WO2006081284A3 (fr) | Procedes pour quantifier de petites molecules d'arn | |
WO2004065601A3 (fr) | Derives lipophiles d'acide ribonucleique a double brin | |
WO2007127919A3 (fr) | Compositions et procédés d'inhibition de l'expression d'un gène du virus jc | |
WO2007133674A3 (fr) | Compositions à base de vecteurs lentiviraux, procédés et applications | |
EP2527445A3 (fr) | Traitement et prévention de la grippe | |
WO2010006973A3 (fr) | Compositions et procédés pour inhiber l’expression de gènes de récepteur tgf-bêta | |
MX2009000654A (es) | Medios para inhibir la expresion de la cinasa de proteina 3. | |
WO2010017319A3 (fr) | Composés d’acide nucléique pour inhiber l’expression du gène plk1 et utilisations de ceux-ci | |
JP2019534025A (ja) | 治療用オリゴヌクレオチドの捕捉および検出 | |
WO2007111998A3 (fr) | Compositions d'arndb et procedes de traitement d'une infection par l'hpv | |
WO2008039937A3 (fr) | Blocage d'une expression génique dans des cellules eukariotes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07765973 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009512639 Country of ref document: JP Ref document number: 2653910 Country of ref document: CA Ref document number: 2007765973 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12302678 Country of ref document: US |